Spyre Therapeutics Inc.

NASDAQ: SYRE · Real-Time Price · USD
17.31
-0.40 (-2.26%)
At close: Jun 13, 2025, 3:59 PM
17.29
-0.12%
After-hours: Jun 13, 2025, 05:50 PM EDT

Spyre Therapeutics Revenue

Spyre Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Spyre Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
73
Market Cap
1.04B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.